EP0700255A1 - Composition de dextrose monohydratee et de glucose - Google Patents

Composition de dextrose monohydratee et de glucose

Info

Publication number
EP0700255A1
EP0700255A1 EP94913846A EP94913846A EP0700255A1 EP 0700255 A1 EP0700255 A1 EP 0700255A1 EP 94913846 A EP94913846 A EP 94913846A EP 94913846 A EP94913846 A EP 94913846A EP 0700255 A1 EP0700255 A1 EP 0700255A1
Authority
EP
European Patent Office
Prior art keywords
weight
composition
homeopathic
potency
titration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94913846A
Other languages
German (de)
English (en)
Other versions
EP0700255A4 (fr
Inventor
Donald Sinclair Hamilton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0700255A1 publication Critical patent/EP0700255A1/fr
Publication of EP0700255A4 publication Critical patent/EP0700255A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A23L2/60—Sweeteners
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention relates to a composition for the treatment of a "hangover" i.e. the after-effects of excessive consumption of ethyl alcohol by a human being.
  • An object of the invention is the provision of a composition which can be taken as a single treatment (in one or more doses) to counteract a hangover.
  • the present invention provides a composition including:- a major proportion of monohydrate dextrose or glucose in combination with the following compounds:
  • liver activity As the liver increases its normal rate of breaking down glycogen into blood sugar, to restore the optimum blood sugar level.
  • Continual or frequent such increase in liver activity can lead to cirrhosis of the liver.
  • the brain uses about 25% of available blood sugar, and so is particularly rapidly effected by a drop in blood sugar levels:- hence the symptoms of slurred speech, memory lapses, headaches, loss of co-ordination, blurred vision, personality changes, and so on commonly associated with alcohol consumption.
  • Monohydrate dextrose breaks down to glucose in the body, and thus both monohydrate dextrose and glucose are quickly and readily assimilated into the blood stream to boost the blood sugar level and help prevent liver damage and counteract brain disfunction.
  • magnesium and potassium salts are magnesium sulphate, magnesium oxide, and potassium phosphate.
  • magnesium and potassium salts may be used.
  • magnesium and potassium salts and vitamin C are much more readily and easily absorbed into the system if taken into the system with monohydrate dextrose or glucose:- the monohydrate dextrose or glucose effectively coats said other constituents and prevents them from being destroyed by stomach acids, and also speeds their circulation around the system.
  • Zinc oxide assists the pancreas with the production of insulin, and hence facilitates the absorption of glucose into the blood.
  • Zinc oxide also is known to be effective in detoxifying the system i.e. combatting the after-effects of alcohol.
  • vitamin B6 in the composition considerably increases the rate of activity of the composition and thus gives more rapid relief to a user. It appears that vitamin B6 and magnesium salts are synergistic i.e. the presence of one increases the effectiveness of the other, and thus reduces the amount of each needed in the composition to achieve the desired effect.
  • the constituents of the composition act to raise the user's blood sugar level and replenish lost vitamin C, magnesium and potassium, and also interact with each other to mutually increase their effectiveness and to speed their assimilation into the system.
  • composition also may contain one or more of the following:
  • a preferred embodiment of the present composition comprises:
  • the composition is in the form of a powder, and is taken dissolved in water or in tablet form. It has been found that the composition is more effective if the user lies on the right side after taking the composition, because this allows the composition to pass more quickly though the duodenum into the intestine, for absorption into the system.
  • the composition may be prepared in liquid form, and drunk or given by injection.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Composition pour le traitement de la 'gueule de bois' consistant en une majeure partie de dextrose monohydratée ou de glucose combinée aux constituants suivants: 0,5% à 2% en poids d'acide ascorbique; un sel non toxique de potassium à dilution 6C dans la classification homéopathique, ou jusqu'à 0,4% en poids; un sel non toxique de magnésium à dilution 6C dans la classification homéopathique, ou jusqu'à 0,4% en poids; de 0,0001% à 2,5% en poids de vitamine B6; de l'oxyde de zinc à dilution 6C dans la classification homéopathique, ou jusqu'à 0,07% en poids.
EP94913846A 1993-05-26 1994-05-10 Composition de dextrose monohydratee et de glucose Withdrawn EP0700255A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ24770193 1993-05-26
NZ24770193 1993-05-26
PCT/NZ1994/000042 WO1994027449A1 (fr) 1993-05-26 1994-05-10 Composition de dextrose monohydratee et de glucose

Publications (2)

Publication Number Publication Date
EP0700255A1 true EP0700255A1 (fr) 1996-03-13
EP0700255A4 EP0700255A4 (fr) 1997-02-26

Family

ID=19924357

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94913846A Withdrawn EP0700255A4 (fr) 1993-05-26 1994-05-10 Composition de dextrose monohydratee et de glucose

Country Status (5)

Country Link
EP (1) EP0700255A4 (fr)
CN (1) CN1124444A (fr)
AU (1) AU676314B2 (fr)
CA (1) CA2162877C (fr)
WO (1) WO1994027449A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601398D0 (en) * 1996-01-24 1996-03-27 Piper Edwina M Composition
FR2748936A1 (fr) * 1996-05-23 1997-11-28 Clergeaud Jean Solution buvable favorisant la baisse du taux d'alcoolemie
FR2748904A1 (fr) * 1996-05-27 1997-11-28 Turpin Veronique Complement nutritionnel personnalise a base de sels biochimiques de schuessler
WO1999026492A1 (fr) * 1997-11-21 1999-06-03 Turpin Veronique Complement nutritionnel a base de sels biochimiques de schuessler
KR100309715B1 (ko) * 1998-04-07 2001-12-28 이명희 구연산회로를활성화시켜알코홀독성과숙취를예방하는기능을가지는조성물
KR100828708B1 (ko) * 2007-06-19 2008-05-09 씨제이제일제당 (주) 숙취의 예방 또는 치료용 조성물
KR101498780B1 (ko) * 2013-04-18 2015-03-04 씨제이제일제당 (주) 숙취의 예방 또는 치료용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH370631A (de) * 1957-05-03 1963-07-15 Heinrich Dr Vogler Verfahren zur Herstellung eines als Zusatz zu Nahrungsmitteln und Getränken bestimmten Präparates
EP0087068A1 (fr) * 1982-02-12 1983-08-31 Thomas Moses Dr. Beck Supplément d'aliments
NL8403433A (nl) * 1984-11-09 1986-06-02 Holland Melkunie Voedingssuppletiepreparaat op basis van melkbestanddelen.
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis

Also Published As

Publication number Publication date
EP0700255A4 (fr) 1997-02-26
WO1994027449A1 (fr) 1994-12-08
CA2162877C (fr) 2004-04-13
AU6584494A (en) 1994-12-20
CN1124444A (zh) 1996-06-12
CA2162877A1 (fr) 1994-12-08
AU676314B2 (en) 1997-03-06

Similar Documents

Publication Publication Date Title
US5053396A (en) Therapeutic composition
US5614224A (en) Nutritional supplement for diabetics
EP0669083B1 (fr) Boisson contenant de la créatine; procédé de préparation
Rastogi et al. Selenium and lead: mutual detoxifying effects
US7498039B2 (en) Nutritional supplement containing sea water minerals
EP0271489B1 (fr) Composition therapeutique
US6867176B2 (en) Method for preparing zinc-oligopeptide easily absorbable by the human body
CA2429117C (fr) Medicament contre le diabete
CA2162877C (fr) Composition a base de dextrose ou de glucose monohydrate
KR100613618B1 (ko) 운동에 동반하여 일어나는 산화적 대사를 지속시키는 방법 및스포츠용 음식물
NZ195881A (en) Pharmaceutical compositions containing cobalt compounds
DE68903147T2 (de) Zusammensetzungen und verfahren zum erlangen einer verbesserten physiologischen reaktion bei leibesuebungen.
US5639482A (en) Composition for control and prevention of diabetic retinopathy
NZ265404A (en) Composition for treatment of hangover
WO2007108712A1 (fr) Kit et procédé servant à traiter ou à prévenir une anémie provoquée par une carence en fer
US20090062231A1 (en) Appetite Suppressant Composition and Method of Appetite Suppression
JP3241173B2 (ja) 入浴剤
JP3793239B2 (ja) アセトアルデヒド毒性の抑制剤
KR20120119686A (ko) Ｌ-아르기닌, 비타민ｃ, 비타민 ｂ군, 비타민ａ, 비타민ｅ 및 요오드화칼륨을 주성분으로 함유하는 기능성 음료조성물
KR20120110955A (ko) 타우린, 이노시톨, 비타민ｃ, 비타민 ｂ군 및 요오드화칼륨을 주성분으로 함유하는 기능성 음료조성물
JP2007314560A (ja) 運動に伴って起こる酸化的代謝を持続させる剤
US4474801A (en) α-Amino-γ-butyrolactones for treating alcohol dependence
Gray The treatment of diabetes mellitus with insoluble insulin compounds
JP2002080376A (ja) 生物活性剤および医薬
US3055805A (en) Process of treating acidosis with t.h.a.m.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19951204

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RAX Requested extension states of the european patent have changed

Free format text: SI PAYMENT 951204

A4 Supplementary search report drawn up and despatched

Effective date: 19970107

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19990329